共 15 条
[1]
A clinical trial of dofetilide in patients with acute myocardial infarction and left ventricular dysfunction: the DIAMOND MI study. Kober L. European Heart Journal . 1998
[2]
Ablation versus medical therapy for atrial fibrillation: who benefit the most. Pappone C,Augello G,Vicedomini G,et al. Pacing and Clinical Electrophysiology . 2003
[3]
Dofetilide in patients with congestive heart failure and left ventricular dysfunction.Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. Torp-Pedersen C,Moller M,Bloch-Thomsen PE,et al. The New England Journal of Medicine . 1999
[4]
Randomized trial of ratecontrol versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. Carlsson J,Miketic S,Windeler J,et al. Journal of the American College of Cardiology . 2003
[5]
Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.SPORTIF II: a dose-guiding, tolerability, and safety study. Petersen P,Grind M,Adler J,et al. Journal of the American College of Cardiology . 2003
[6]
A comparison of rate control and rhythm control in patients with atrial fibrillation. The AFFIRM Investigators. The New England Journal of Medicine . 2002
[7]
Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation(PIAF): a randomized trial. Hohnloser SH,Kuck HH,Lilienthal J,et al. The Lancet . 2000
[8]
The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial(AIRCRAFT). Weerasooriya R,Davis M,Powell A,et al. Journal of the American College of Cardiology . 2003
[9]
Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. Oral H,Souza JJ,Michaud GF,et al. The New England Journal of Medicine . 1999
[10]
Efficacy and safety of oral dofetilide in maintaining normal sinus in patients with atrial fibrillation flutter: a multicenter study. Singh S,Berk M,Yellen L,et al. Circulation . 1997